Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.

NCT07593482 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

B-cell Lymphoma

Interventions

DRUG: bendamustine hydrochloride
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

Swiss Cancer Institute